Blog Archives

PRESS RELEASE: CLEVEMED ISSUES ONLINE UPDRS SCORING CHALLENGE TO HIGHLIGHT BENEFITS OF KINESIA™ AUTOMATED TREMOR SCORING

VIEW PRESS RELEASE [PDF]

CLEVELAND, Ohio (March 24, 2009) – Cleveland Medical Devices Inc. (CleveMed) announced the release of automated tremor scoring for Kinesia™, a compact patient worn device for assessing Parkinson’s disease (PD) motor symptom severity. To demonstrate the benefits of Kinesia and the new tremor scoring feature,

Read more ›



PRESS RELEASE: CLEVEMED LAUNCHES CLINICIAL STUDY MONITORING PARKINSON’S DISEASE MOTOR SYMPTOMS IN THE CLINIC AND AT HOME USING KINESIA™

VIEW PRESS RELEASE [PDF]

CLEVELAND, Ohio (January 28, 2009) – Cleveland Medical Devices Inc. (CleveMed) has launched a large scale multicenter clinical study to continue development and validation of Kinesia™, a compact wireless system for monitoring severity of Parkinson’s disease (PD) motor symptoms. Kinesia uses miniature motion sensors worn on the hand and wirelessly transmits motor symptom information to a PC.

Read more ›



PRESS RELEASE: CLEVEMED RECEIVES $1.23 MILLION IN NIH FUNDING TO DEVELOP A SYSTEM TO AUGMENT DEEP BRAIN STIMULATION PROGRAMMING IN PARKINSON´S DISEASE

VIEW PRESS RELEASE [PDF]

CLEVELAND, OHIO, OCT 7, 2008 – Cleveland Medical Devices Inc. (CleveMed) announced it has been awarded $1.23 million in NIH SBIR FastTrack funding from the National Institute on Aging to develop ParkinTune™, a system to augment stimulator programming in deep brain stimulation (DBS) procedures for Parkinson´s disease (PD).

Read more ›



Comparison of Kinesia to the Unified Parkinson’s Disease Rating Scale: Tremor and Bradykinesia Results

D. Heldman, Ph.D., David E. Riley, M.D., Brian N. Maddux, M.D., Ph.D.,J. Giuffrida, Ph.D.
Presented at the 2008 American Academy of Neurology Annual Meeting

Read more ›



Top